DARAZADEX: a Phase II trial of daratumumab plus azacitidine and dexamethasone in R/R myeloma
Nina Shah • 1 Dec 2020
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter